Risks and benefits of ovarian shielding in female patients undergoing TBI: a decision analysis

被引:4
作者
Kanda, Y. [1 ]
Sakamoto, K. [1 ]
Ashizawa, M. [1 ]
Sato, M. [1 ]
Terasako, K. [1 ]
Kikuchi, M. [1 ]
Kimura, S-I [1 ]
Okuda, S. [1 ]
Kako, S. [1 ]
Oshima, K. [1 ]
机构
[1] Jichi Med Univ, Div Hematol, Saitama Med Ctr, Saitama, Japan
关键词
STEM-CELL TRANSPLANTATION; RETROSPECTIVE ANALYSIS; CRYOPRESERVATION; LEUKEMIA;
D O I
10.1038/bmt.2010.240
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:1145 / 1147
页数:3
相关论文
共 10 条
[1]   Tumor cell contamination in ovarian tissue cryopreserved before gonadotoxic treatment: should we systematically exclude ovarian autograft in a cancer survivor? [J].
Courbiere, B. ;
Prebet, T. ;
Mozziconacci, M-J ;
Metzler-Guillemain, C. ;
Saias-Magnan, J. ;
Gamerre, M. .
BONE MARROW TRANSPLANTATION, 2010, 45 (07) :1247-1248
[2]   Highly efficient vitrification method for cryopreservation of human oocytes [J].
Kuwayama, M ;
Vajta, G ;
Kato, O ;
Leibo, SP .
REPRODUCTIVE BIOMEDICINE ONLINE, 2005, 11 (03) :300-308
[3]  
Nagashima T, 2005, MED SCI MONITOR, V11, pCR91
[4]   Ovarian shielding allows ovarian recovery and normal birth in female hematopoietic SCT recipients undergoing TBI [J].
Nakagawa, K. ;
Kanda, Y. ;
Yamashita, H. ;
Nakagawa, S. ;
Sasano, N. ;
Ohtomo, K. ;
Oshima, K. ;
Kumano, K. ;
Ban, N. ;
Minamitani, Y. ;
Kurokawa, M. ;
Chiba, S. .
BONE MARROW TRANSPLANTATION, 2008, 42 (10) :697-699
[5]   Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: A large-scale retrospective analysis of data from the Japan society for hematopoietic cell transplantation [J].
Ogawa, H ;
Ikegame, K ;
Kawakami, M ;
Takahashi, S ;
Sakamaki, H ;
Karasuno, T ;
Sao, H ;
Kodera, Y ;
Hirabayashi, N ;
Okamoto, S ;
Harada, M ;
Iwato, K ;
Maruta, A ;
Tanimoto, M ;
Kawa, K .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (05) :495-500
[6]   Efficiency of oocyte cryopreservation: a meta-analysis [J].
Oktay, Kutluk ;
Cil, Aylin Pelin ;
Bang, Heejung .
FERTILITY AND STERILITY, 2006, 86 (01) :70-80
[7]   Should busulfan-containing regimen be avoided for young female patients undergoing hematopoietic stem cell transplantation? [J].
Okuda, S. ;
Sato, M. ;
Terasako, K. ;
Kako, S. ;
Oshima, K. ;
Kanda, Y. .
BONE MARROW TRANSPLANTATION, 2009, 43 (03) :261-262
[8]   Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis [J].
Scott, BL ;
Sandmaier, BM ;
Storer, B ;
Maris, MB ;
Sorror, ML ;
Maloney, DG ;
Chauncey, TR ;
Storb, R ;
Deeg, HJ .
LEUKEMIA, 2006, 20 (01) :128-135
[9]   Nonmalignant late effects after allogeneic stem cell transplantation [J].
Socié, G ;
Salooja, N ;
Cohen, A ;
Rovelli, A ;
Carreras, E ;
Locasciulli, A ;
Korthof, E ;
Weis, J ;
Levy, V ;
Tichelli, A .
BLOOD, 2003, 101 (09) :3373-3385
[10]  
The Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology, 2008, FERTIL STERIL, V90, pS241